Lori Morton

906 total citations
16 papers, 243 citations indexed

About

Lori Morton is a scholar working on Immunology, Hematology and Infectious Diseases. According to data from OpenAlex, Lori Morton has authored 16 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Hematology and 3 papers in Infectious Diseases. Recurrent topics in Lori Morton's work include Complement system in diseases (6 papers), Blood groups and transfusion (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Lori Morton is often cited by papers focused on Complement system in diseases (6 papers), Blood groups and transfusion (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Lori Morton collaborates with scholars based in United States, South Korea and Israel. Lori Morton's co-authors include Kishor Devalaraja‐Narashimha, Theodore Kaplan, Gábor Halász, Scott M. MacDonnell, Qin Ruan, Yi Wei, Christina Adler, Yong Kim, Wen Zhang and Min Ni and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of the American College of Cardiology.

In The Last Decade

Lori Morton

15 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lori Morton United States 8 90 64 57 39 28 16 243
Masato Moriyama Japan 10 67 0.7× 61 1.0× 38 0.7× 50 1.3× 13 0.5× 35 298
Jennifer A. C. van Hulst Netherlands 12 183 2.0× 56 0.9× 100 1.8× 23 0.6× 24 0.9× 16 305
Sahithi J. Kuravi United Kingdom 7 41 0.5× 98 1.5× 82 1.4× 10 0.3× 16 0.6× 9 215
Xavier Heim France 8 54 0.6× 53 0.8× 36 0.6× 8 0.2× 21 0.8× 15 194
Jie Zi China 10 45 0.5× 100 1.6× 32 0.6× 24 0.6× 39 1.4× 32 256
In Seol Yoo South Korea 11 35 0.4× 87 1.4× 142 2.5× 13 0.3× 11 0.4× 31 317
Vijetha Kumar United States 3 95 1.1× 36 0.6× 34 0.6× 9 0.2× 33 1.2× 6 210
Tomoyuki Sasaki Japan 8 35 0.4× 81 1.3× 76 1.3× 22 0.6× 29 1.0× 16 268
Anshul Badhwar United States 6 207 2.3× 102 1.6× 134 2.4× 43 1.1× 11 0.4× 10 303
Lucia Ciucciarelli Italy 8 79 0.9× 69 1.1× 55 1.0× 6 0.2× 22 0.8× 9 270

Countries citing papers authored by Lori Morton

Since Specialization
Citations

This map shows the geographic impact of Lori Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Morton more than expected).

Fields of papers citing papers by Lori Morton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Morton. The network helps show where Lori Morton may publish in the future.

Co-authorship network of co-authors of Lori Morton

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Morton. A scholar is included among the top collaborators of Lori Morton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Morton. Lori Morton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Thomas, Marie, Davor Frleta, KehDih Lai, et al.. (2025). Interplay of procoagulatory and neutrophil-derived anticoagulatory proteins in C1q-NET–driven blood coagulation. Blood. 146(24). 2993–3002.
2.
Patel, Siddharth M., Mathew S. Lopes, David A. Morrow, et al.. (2024). Targeted proteomic profiling of cardiogenic shock in the cardiac intensive care unit. European Heart Journal Acute Cardiovascular Care. 13(8). 624–628. 2 indexed citations
3.
Kithcart, Aaron, Kishor Devalaraja‐Narashimha, Laura Liu, et al.. (2024). EFFECTS OF REGN5381, A NATRIURETIC PEPTIDE RECEPTOR 1 AGONIST ANTIBODY, IN HYPERTENSIVE MOUSE MODELS AND MILDLY HYPERTENSIVE BUT OTHERWISE HEALTHY ADULTS IN A PHASE 1 FIRST-IN-HUMAN STUDY. Journal of the American College of Cardiology. 83(13). 1706–1706. 1 indexed citations
4.
Zhu, Yuan, Scott M. MacDonnell, Theodore Kaplan, et al.. (2023). Defining a Unique Gene Expression Profile in Mature and Developing Keloids. SHILAP Revista de lepidopterología. 3(5). 100211–100211. 3 indexed citations
5.
Devalaraja‐Narashimha, Kishor, Peter J. Ehmann, Cong Huang, et al.. (2022). Association of complement pathways with COVID-19 severity and outcomes. Microbes and Infection. 25(4). 105081–105081. 9 indexed citations
6.
MacDonnell, Scott M., Qin Ruan, Gábor Halász, et al.. (2022). Activin A directly impairs human cardiomyocyte contractile function indicating a potential role in heart failure development. Frontiers in Cardiovascular Medicine. 9. 1038114–1038114. 10 indexed citations
7.
Devalaraja‐Narashimha, Kishor, Cong Huang, Yaping Chen, et al.. (2022). Pharmacokinetics and pharmacodynamics of pozelimab alone or in combination with cemdisiran in non-human primates. PLoS ONE. 17(6). e0269749–e0269749. 15 indexed citations
8.
Abedini, Amin, Mustafa Al‐Obaidi, Kishor Devalaraja‐Narashimha, et al.. (2022). An Interim Analysis of Clinical and Histopathological Results of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study. Journal of the American Society of Nephrology. 33(11S). 119–119. 1 indexed citations
9.
Zhang, Qian, Peter J. Ehmann, Jianing Xu, et al.. (2021). The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized Patients. Molecular and Cellular Biology. 42(1). e0046721–e0046721. 8 indexed citations
10.
Jang, Jun‐Ho, Jonathan Weyne, Umesh Chaudhari, et al.. (2021). Pozelimab, a Human Monoclonal Antibody Against Complement Factor C5, Provided Inhibition of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria. Blood. 138(Supplement 1). 1128–1128. 6 indexed citations
11.
Chodick, Gabriel, Ni Yan, Dan Chalothorn, et al.. (2021). The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events. Thrombosis and Haemostasis. 122(5). 808–817. 27 indexed citations
12.
Chang, Raymond, et al.. (2021). Development of a semi-automated segmentation tool for high frequency ultrasound image analysis of mouse echocardiograms. Scientific Reports. 11(1). 5 indexed citations
13.
14.
MacDonnell, Scott M., Luis Cheng, Yong Kim, et al.. (2019). Defining the Activated Fibroblast Population in Lung Fibrosis Using Single-Cell Sequencing. American Journal of Respiratory Cell and Molecular Biology. 61(1). 74–85. 133 indexed citations
15.
Devalaraja‐Narashimha, Kishor, Ni Yan, Cong Huang, et al.. (2019). Pozelimab, a Human Antibody Against Complement Factor C5, Demonstrates Robust Inhibition of Alternative Complement Activity Both in Normal Human Serum and in Phase I Normal Healthy Volunteers. Blood. 134(Supplement_1). 2278–2278. 7 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masato Moriyama Breakdown of academic impact, for papers by Jennifer A. C. van Hulst Breakdown of academic impact, for papers by Sahithi J. Kuravi Breakdown of academic impact, for papers by Xavier Heim Breakdown of academic impact, for papers by Jie Zi Breakdown of academic impact, for papers by In Seol Yoo Breakdown of academic impact, for papers by Vijetha Kumar Breakdown of academic impact, for papers by Tomoyuki Sasaki Breakdown of academic impact, for papers by Anshul Badhwar Breakdown of academic impact, for papers by Lucia Ciucciarelli
Rankless by CCL
2026